Circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma
- Resource Type
- Article
- Source
- In
Journal of Infection and Chemotherapy April 2017 23(4):196-200 - Subject
- Language
- ISSN
- 1341-321X